Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease Academic Article Article uri icon

Overview

MeSH Major

  • Bile Duct Neoplasms
  • Bile Ducts, Extrahepatic
  • Cholangiocarcinoma
  • Neoplasm Staging
  • Preoperative Care

abstract

  • Standard preoperative investigations predicted resectability in 79% of patients with hepatic colorectal metastases. Unresectable disease limited to the liver and extrahepatic disease were seen with nearly equal frequency. The majority of patients with extrahepatic metastases had resectable hepatic disease (31 of 43, 72%). A preoperative scoring system is proposed that identifies patients at high risk for unrecognized irresectable disease and may help focus the use of additional diagnostic modalities such as laparoscopy and positron emission tomography (PET).

publication date

  • January 1999

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1072-7515(98)00272-5

PubMed ID

  • 9915240

Additional Document Info

start page

  • 33

end page

  • 42

volume

  • 188

number

  • 1